HEADER TRANSCRIPTION 11-MAR-99 2GWX TITLE MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- TITLE 2 ACTIVATED RECEPTORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (PPAR-DELTA); COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BIDING DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE30); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSETA WITH T7 PROMOTER KEYWDS PPAR, FATTY ACIDS, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD EXPDTA X-RAY DIFFRACTION AUTHOR H.E.XU,M.H.LAMBERT,V.G.MONTANA,D.J.PARK,S.BLANCHARD,P.BROWN, AUTHOR 2 D.STERNBACH,J.LEHMANN,G.W.BRUCE,T.M.WILLSON,S.A.KLIEWER,M.V.MILBURN REVDAT 4 27-DEC-23 2GWX 1 SEQADV REVDAT 3 24-FEB-09 2GWX 1 VERSN REVDAT 2 23-SEP-03 2GWX 1 SEQADV REVDAT 1 11-MAR-00 2GWX 0 JRNL AUTH H.E.XU,M.H.LAMBERT,V.G.MONTANA,D.J.PARKS,S.G.BLANCHARD, JRNL AUTH 2 P.J.BROWN,D.D.STERNBACH,J.M.LEHMANN,G.B.WISELY,T.M.WILLSON, JRNL AUTH 3 S.A.KLIEWER,M.V.MILBURN JRNL TITL MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTORS. JRNL REF MOL.CELL V. 3 397 1999 JRNL REFN ISSN 1097-2765 JRNL PMID 10198642 JRNL DOI 10.1016/S1097-2765(00)80467-0 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.5 REMARK 3 NUMBER OF REFLECTIONS : 26881 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2661 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3299 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE : 0.2780 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 327 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4199 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 185 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.56000 REMARK 3 B22 (A**2) : -0.54000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.87000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.00 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.07 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.220 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.090 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.380 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.640 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.57 REMARK 3 BSOL : 114.2 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2GWX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAR-99. REMARK 100 THE DEPOSITION ID IS D_1000000628. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 9.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.11100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 243 CG ND1 CD2 CE1 NE2 REMARK 470 VAL A 263 CG1 CG2 REMARK 470 LYS A 265 CG CD CE NZ REMARK 470 GLN A 266 CG CD OE1 NE2 REMARK 470 LEU A 267 CG CD1 CD2 REMARK 470 VAL A 268 CG1 CG2 REMARK 470 PRO A 272 CG CD REMARK 470 TYR A 274 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLN A 470 CG CD OE1 NE2 REMARK 470 MET A 476 CA C O CB CG SD CE REMARK 470 SER B 215 OG REMARK 470 THR B 238 OG1 CG2 REMARK 470 HIS B 243 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 267 CG CD1 CD2 REMARK 470 VAL B 268 CG1 CG2 REMARK 470 TYR B 274 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 LYS B 336 CG CD CE NZ REMARK 470 GLN B 429 CG CD OE1 NE2 REMARK 470 GLN B 430 CG CD OE1 NE2 REMARK 470 LYS B 434 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 245 C - N - CA ANGL. DEV. = 15.5 DEGREES REMARK 500 ALA A 245 N - CA - C ANGL. DEV. = 32.7 DEGREES REMARK 500 PRO A 246 C - N - CD ANGL. DEV. = -18.6 DEGREES REMARK 500 PRO B 433 C - N - CA ANGL. DEV. = 10.7 DEGREES REMARK 500 PRO B 433 C - N - CD ANGL. DEV. = -18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 238 96.60 64.18 REMARK 500 LYS A 240 -50.44 -171.60 REMARK 500 ALA A 241 39.24 -91.75 REMARK 500 SER A 242 145.62 -21.40 REMARK 500 HIS A 243 -82.85 -120.18 REMARK 500 ALA A 245 -41.63 -5.28 REMARK 500 PRO A 246 109.25 20.10 REMARK 500 GLU A 259 22.89 -67.85 REMARK 500 LYS A 260 -53.98 -146.26 REMARK 500 VAL A 263 -166.90 56.18 REMARK 500 TRP A 264 -50.35 162.09 REMARK 500 LYS A 265 119.31 30.64 REMARK 500 GLN A 266 -50.00 164.66 REMARK 500 LEU A 267 -88.94 -117.01 REMARK 500 VAL A 268 57.79 33.31 REMARK 500 TYR A 274 20.80 -165.53 REMARK 500 LEU A 311 -37.39 -39.56 REMARK 500 ARG A 357 156.74 -48.45 REMARK 500 ASN A 402 70.55 -108.67 REMARK 500 GLU A 460 71.17 -105.17 REMARK 500 LYS A 474 -34.06 -31.74 REMARK 500 LYS B 232 -45.27 174.57 REMARK 500 LEU B 237 127.55 157.88 REMARK 500 THR B 238 -83.14 173.59 REMARK 500 LYS B 240 -150.72 -151.18 REMARK 500 SER B 242 31.72 -65.03 REMARK 500 HIS B 243 12.36 -65.96 REMARK 500 THR B 244 -56.95 -155.07 REMARK 500 ALA B 245 96.94 59.24 REMARK 500 LEU B 262 -20.65 -149.76 REMARK 500 VAL B 263 89.47 58.00 REMARK 500 TRP B 264 -116.57 -102.06 REMARK 500 LYS B 265 -128.47 -140.11 REMARK 500 GLN B 266 90.72 38.44 REMARK 500 LEU B 267 134.75 -37.28 REMARK 500 VAL B 268 -160.27 46.98 REMARK 500 LEU B 271 53.50 77.71 REMARK 500 PRO B 272 -154.04 -102.62 REMARK 500 PRO B 304 -87.05 -13.77 REMARK 500 ALA B 342 88.15 44.64 REMARK 500 ASN B 343 5.43 58.92 REMARK 500 LYS B 358 -49.45 -21.91 REMARK 500 ASN B 402 76.32 -110.52 REMARK 500 ALA B 423 -72.24 -68.35 REMARK 500 ALA B 428 -168.92 -49.77 REMARK 500 REMARK 500 REMARK: NULL DBREF 2GWX A 211 477 UNP Q03181 PPAS_HUMAN 175 441 DBREF 2GWX B 211 477 UNP Q03181 PPAS_HUMAN 175 441 SEQADV 2GWX GLN A 430 UNP Q03181 TYR 394 CONFLICT SEQADV 2GWX GLN B 430 UNP Q03181 TYR 394 CONFLICT SEQRES 1 A 267 LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR LEU SEQRES 2 A 267 LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER ILE SEQRES 3 A 267 LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL ILE SEQRES 4 A 267 HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY LEU SEQRES 5 A 267 VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR LYS SEQRES 6 A 267 GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS THR SEQRES 7 A 267 THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA LYS SEQRES 8 A 267 SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP GLN SEQRES 9 A 267 VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE PHE SEQRES 10 A 267 ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU LEU SEQRES 11 A 267 VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE LEU SEQRES 12 A 267 ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU PRO SEQRES 13 A 267 LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU SEQRES 14 A 267 ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE ILE SEQRES 15 A 267 LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO ARG SEQRES 16 A 267 VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU GLU SEQRES 17 A 267 PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN LEU SEQRES 18 A 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN SEQRES 19 A 267 LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE LYS SEQRES 20 A 267 LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU GLN SEQRES 21 A 267 GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 267 LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR LEU SEQRES 2 B 267 LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER ILE SEQRES 3 B 267 LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL ILE SEQRES 4 B 267 HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY LEU SEQRES 5 B 267 VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR LYS SEQRES 6 B 267 GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS THR SEQRES 7 B 267 THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA LYS SEQRES 8 B 267 SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP GLN SEQRES 9 B 267 VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE PHE SEQRES 10 B 267 ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU LEU SEQRES 11 B 267 VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE LEU SEQRES 12 B 267 ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU PRO SEQRES 13 B 267 LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU SEQRES 14 B 267 ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE ILE SEQRES 15 B 267 LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO ARG SEQRES 16 B 267 VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU GLU SEQRES 17 B 267 PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN LEU SEQRES 18 B 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN SEQRES 19 B 267 LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE LYS SEQRES 20 B 267 LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU GLN SEQRES 21 B 267 GLU ILE TYR LYS ASP MET TYR FORMUL 3 HOH *185(H2 O) HELIX 1 1 LYS A 212 ASN A 225 1 14 HELIX 2 2 LYS A 230 ILE A 236 1 7 HELIX 3 3 ILE A 252 ALA A 258 1 7 HELIX 4 4 ILE A 277 LYS A 301 1 25 HELIX 5 5 PRO A 304 SER A 308 1 5 HELIX 6 6 LEU A 311 ILE A 333 1 23 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 PHE A 360 ASP A 362 5 3 HELIX 9 9 GLU A 365 LEU A 377 1 13 HELIX 10 10 ASP A 381 ILE A 392 1 12 HELIX 11 11 VAL A 403 ASN A 424 1 22 HELIX 12 12 LEU A 431 THR A 459 1 29 HELIX 13 13 PRO A 467 TYR A 473 1 7 HELIX 14 14 LYS B 212 ASN B 225 1 14 HELIX 15 15 LYS B 230 ALA B 233 1 4 HELIX 16 16 ILE B 252 ALA B 258 1 7 HELIX 17 17 ILE B 277 SER B 302 1 26 HELIX 18 18 LEU B 311 MET B 329 1 19 HELIX 19 19 ALA B 331 ILE B 333 5 3 HELIX 20 20 ARG B 350 SER B 355 1 6 HELIX 21 21 PHE B 360 ASP B 362 5 3 HELIX 22 22 GLU B 365 LEU B 377 1 13 HELIX 23 23 ASP B 381 ILE B 392 1 12 HELIX 24 24 VAL B 403 ASN B 424 1 22 HELIX 25 25 PHE B 432 THR B 459 1 28 HELIX 26 26 PRO B 467 ASP B 475 1 9 SHEET 1 A 3 PHE A 247 ILE A 249 0 SHEET 2 A 3 GLY A 346 THR A 349 1 N PHE A 347 O PHE A 247 SHEET 3 A 3 GLY A 338 VAL A 341 -1 N VAL A 341 O GLY A 346 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 N PHE B 347 O PHE B 247 SHEET 3 B 3 GLY B 338 VAL B 341 -1 N VAL B 341 O GLY B 346 CRYST1 39.772 94.222 96.701 90.00 97.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025143 0.000000 0.003431 0.00000 SCALE2 0.000000 0.010613 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010437 0.00000